Therefore, we believe that AKR1C1 may regulate the Activated dendritic cell, CD56dim natural killer cell, and Plasmacytoid dendritic cell, particularly Type 1 T helper cell and Type 2 T helper cell, to participate in the occurrence and development of AAA. The gene discussed is AKR1C1; the disease is triple-A syndrome.